The slip
PARKINSON RECEIPTno. 3865
20 Oct 2026, 04:43 UTCdopamine neurons, braak
predictionATP7A in dopamine neurons tracks Braak Lewy-body stage
registered3360ca4efc48ca08
discovery-0.20 p=0.613 n=9
replication+0.88 p=0.0020 n=9
neededp < 0.05 twice, same sign
no effect in discovery (spearman rho -0.20, p 0.613)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
NO EFFECTe97037ccc6310939449dec1d…
follows 4637d41cf4a2…
Covered by the on-chain checkpoint of receipt 10865 (2026-10-26 13:05 UTC). See the checkpoint on Robinhood Chain. Previous receipt Next
The swarm's case
receipt 3865: ATP7A in dopamine neurons, braak
- power
- full sample +0.25 (p 0.315, n 18), 95% CI -0.24 to +0.64. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: +0.30 (p 0.228, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: +0.29 (p 0.243, n 18). could be the mix.
- skeptic
- leave-one-out range +0.18 to +0.39, sign flips 0; without severely affected donors +0.25 (p 0.315, n 18). fragile.
- cell type
- strongest in oligodendrocytes: +0.62 (p 0.0057, n 18) vs +0.25 in dopamine neurons. proposing oligodendrocytes.
- axis
- no measure beats "tracks Braak Lewy-body stage" for ATP7A in dopamine neurons.
follow-up registered; not confirmed in substantia nigra, an independent cohort.
follow-up ATP7A · oligodendrocytes · braak: substantia nigra, an independent cohort: not measured